Bioharvest Sciences Inc (BHSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 428 | 433 | 385 | 407 | 399 |
| Accounts receivable | -274 | -477 | 33 | -242 | -419 |
| Other Working Capital | 9 | -1,528 | -768 | 343 | 11 |
| Other Operating Activity | -1,542 | -680 | -1,741 | -1,964 | -1,418 |
| Operating Cash Flow | $-1,379 | $-2,252 | $-2,091 | $-1,456 | $-1,427 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -593 | -654 | -425 | -592 | -684 |
| Purchase Of Investment | -1,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -14 | 0 | 0 | 4 |
| Investing Cash Flow | $-1,593 | $-668 | $-425 | $-592 | $-680 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | N/A | N/A | N/A | 3,343 |
| Debt Issued | N/A | 2,096 | N/A | N/A | N/A |
| Debt Repayment | -705 | -6,253 | -424 | -256 | -221 |
| Common Stock Issued | N/A | 18,262 | 0 | N/A | N/A |
| Other Financing Activity | -135 | 838 | 10,160 | 2,642 | 0 |
| Financing Cash Flow | $-840 | $14,943 | $9,736 | $2,386 | $3,122 |
| Exchange Rate Effect | -46 | 36 | 19 | -12 | -4 |
| Beginning Cash Position | 23,025 | 10,966 | 3,727 | 3,401 | 2,390 |
| End Cash Position | 19,167 | 23,025 | 10,966 | 3,727 | 3,401 |
| Net Cash Flow | $-3,812 | $12,023 | $7,220 | $338 | $1,015 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,379 | -2,252 | -2,091 | -1,456 | -1,427 |
| Capital Expenditure | -593 | -654 | -425 | -592 | -684 |
| Free Cash Flow | -1,972 | -2,906 | -2,516 | -2,048 | -2,111 |